Giant multilocular prostatic cystadenoma:a case report and literature review
10.3969/j.issn.1009-8291.2023.03.012
- VernacularTitle:巨大多房性前列腺囊腺瘤1例报告并文献复习
- Author:
Shiying TANG
1
;
Yu TIAN
1
;
Peng HONG
1
;
Min LU
2
;
Chunlei XIAO
1
;
Jian LU
1
;
Lulin MA
1
Author Information
1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
2. Department of Pathology, Peking University Third Hospital, Beijing 100191, China
- Publication Type:Journal Article
- Keywords:
multilocular prostatic cystadenoma;
giant tumor;
lower urinary tract symptoms;
clinical features;
treatment strategies
- From:
Journal of Modern Urology
2023;28(3):232-237
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the clinical characteristics and treatment strategy of giant multilocular prostatic cystadenoma(GMPC). 【Methods】 The clinical data of a GMPC patient treated in our hospital in July 2021 were retrospectively analyzed. The patient was 73 years old. The clinical manifestations were urgent urination and frequent urination. The prostate specific antigen (PSA) increased slightly. MRI showed giant cystic solid space occupying lesion of the prostate. Domestic and foreign cases of prostate cystadenoma from 2000 to 2021 were retrieved for literature review. 【Results】 Transabdominal laparoscopic radical prostatectomy was performed successfully. The postoperative pathological diagnosis was GMPC. Two weeks after operation, the urinary catheter was removed, and there was no discomfort such as urinary frequency or urinary incontinence. After follow-up for more than 8 months, there was no tumor recurrence or metastasis. 【Conclusion】 There are still some disputes about the oncological characteristics and diagnosis and treatment of GMPC, and there is a lack of long-term follow-up results. Laparoscopic prostatectomy is safe and feasible. Most patients have a good prognosis after surgical treatment. It is necessary to formulate an individualized standard treatment plan based on surgery combined with different patients’ conditions to actively improve the prognosis.
